Hongwu Wang

10.4k total citations · 1 hit paper
37 papers, 3.8k citations indexed

About

Hongwu Wang is a scholar working on Epidemiology, Immunology and Hepatology. According to data from OpenAlex, Hongwu Wang has authored 37 papers receiving a total of 3.8k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Epidemiology, 11 papers in Immunology and 9 papers in Hepatology. Recurrent topics in Hongwu Wang's work include Liver Disease Diagnosis and Treatment (15 papers), Hepatitis B Virus Studies (7 papers) and Immune Cell Function and Interaction (6 papers). Hongwu Wang is often cited by papers focused on Liver Disease Diagnosis and Treatment (15 papers), Hepatitis B Virus Studies (7 papers) and Immune Cell Function and Interaction (6 papers). Hongwu Wang collaborates with scholars based in China, Taiwan and United States. Hongwu Wang's co-authors include Qin Ning, Xiaoping Luo, Meifang Han, Di Wu, Huilong Chen, Wei Guo, Haijing Yu, Da Huang, Shiji Wu and Jianping Zhao and has published in prestigious journals such as Journal of Clinical Investigation, SHILAP Revista de lepidopterología and The Journal of Immunology.

In The Last Decade

Hongwu Wang

34 papers receiving 3.8k citations

Hit Papers

Clinical and immunologica... 2020 2026 2022 2024 2020 1000 2.0k 3.0k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hongwu Wang China 14 2.7k 1.5k 578 554 520 37 3.8k
Haijing Yu China 9 2.7k 1.0× 1.6k 1.0× 385 0.7× 425 0.8× 445 0.9× 14 3.5k
Da Huang China 16 2.6k 1.0× 1.5k 1.0× 461 0.8× 473 0.9× 818 1.6× 78 4.0k
Shiji Wu China 18 3.4k 1.3× 1.8k 1.2× 559 1.0× 787 1.4× 567 1.1× 47 4.6k
Ziwei Hu China 9 3.4k 1.3× 1.9k 1.2× 440 0.8× 459 0.8× 412 0.8× 22 4.3k
Shuoqi Zhang China 8 3.4k 1.3× 1.9k 1.3× 422 0.7× 437 0.8× 396 0.8× 10 4.2k
Cuihong Xie China 9 3.4k 1.3× 1.9k 1.2× 410 0.7× 443 0.8× 434 0.8× 9 4.4k
Meifang Han China 23 2.9k 1.1× 1.6k 1.1× 1.2k 2.0× 739 1.3× 693 1.3× 59 4.9k
Chek Meng Poh Singapore 12 2.1k 0.8× 926 0.6× 298 0.5× 712 1.3× 573 1.1× 17 3.6k
Bo Diao China 15 1.9k 0.7× 1.0k 0.7× 239 0.4× 456 0.8× 501 1.0× 41 2.8k
Inge Hamming Netherlands 14 3.5k 1.3× 1.7k 1.1× 373 0.6× 315 0.6× 721 1.4× 21 5.4k

Countries citing papers authored by Hongwu Wang

Since Specialization
Citations

This map shows the geographic impact of Hongwu Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hongwu Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hongwu Wang more than expected).

Fields of papers citing papers by Hongwu Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hongwu Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hongwu Wang. The network helps show where Hongwu Wang may publish in the future.

Co-authorship network of co-authors of Hongwu Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Hongwu Wang. A scholar is included among the top collaborators of Hongwu Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hongwu Wang. Hongwu Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Hu, Danqing, Peng Wang, Xiaojing Wang, et al.. (2024). The efficacy of antiviral treatment in chronic hepatitis B patients with hepatic steatosis. Heliyon. 10(7). e28653–e28653. 3 indexed citations
4.
Qin, Xiaofei, et al.. (2023). Comparison of Biological Characteristics of Human Umbilical Cord Wharton’s Jelly-Derived Mesenchymal Stem Cells from Extremely Preterm and Term Infants. Tissue Engineering and Regenerative Medicine. 20(5). 725–737. 4 indexed citations
5.
Hu, Danqing, Peng Wang, Xiaojing Wang, et al.. (2023). Disease severity and antiviral response in patients with chronic hepatitis B with non-obese NAFLD. Journal of the Formosan Medical Association. 123(7). 773–780. 1 indexed citations
6.
Ning, Qin, Di Wu, Xiaojing Wang, et al.. (2022). The mechanism underlying extrapulmonary complications of the coronavirus disease 2019 and its therapeutic implication. Signal Transduction and Targeted Therapy. 7(1). 57–57. 57 indexed citations
7.
8.
Wang, Hongwu, Junjian Hu, Ran Tao, et al.. (2022). Fibrinogen-like protein 2 deficiency inhibits virus-induced fulminant hepatitis through abrogating inflammatory macrophage activation. World Journal of Gastroenterology. 28(4). 479–496. 8 indexed citations
9.
Gao, Qiang, Wenhui Wu, Junjian Hu, et al.. (2022). FGL2–MCOLN3-Autophagy Axis–Triggered Neutrophil Extracellular Traps Exacerbate Liver Injury in Fulminant Viral Hepatitis. Cellular and Molecular Gastroenterology and Hepatology. 14(5). 1077–1101. 26 indexed citations
10.
11.
Zhang, Meng, Hongwu Wang, Yuancheng Huang, et al.. (2021). Compound heterozygous UGT1A1*28 and UGT1A1*6 or single homozygous UGT1A1*28 are major genotypes associated with Gilbert’s syndrome in Chinese Han people. Gene. 781. 145526–145526. 7 indexed citations
12.
Wu, Ting, Junjian Hu, Xiaojing Wang, et al.. (2021). High‐fat‐induced nonalcoholic fatty liver potentiates vulnerability to and the severity of viral hepatitis in a C3H/HeN mouse model. BioFactors. 48(1). 216–227. 1 indexed citations
13.
Han, Meifang, Ke Ma, Xiaojing Wang, et al.. (2021). Immunological Characteristics in Type 2 Diabetes Mellitus Among COVID-19 Patients. Frontiers in Endocrinology. 12. 596518–596518. 31 indexed citations
14.
Chen, Guang, Di Wu, Wei Guo, et al.. (2020). Clinical and immunological features of severe and moderate coronavirus disease 2019. Journal of Clinical Investigation. 130(5). 2620–2629. 3242 indexed citations breakdown →
15.
16.
Wang, Xiaojing, Li Lan, Hongwu Wang, Fang Xiao, & Qin Ning. (2019). Epoxyeicosatrienoic acids alleviate methionine‐choline‐deficient diet–induced non‐alcoholic steatohepatitis in mice. Scandinavian Journal of Immunology. 90(3). e12791–e12791. 22 indexed citations
17.
Yu, Haijing, Yang Liu, Hongwu Wang, et al.. (2018). Clara Cell 10 kDa Protein Alleviates Murine Hepatitis Virus Strain 3-Induced Fulminant Hepatitis by Inhibiting Fibrinogen-Like Protein 2 Expression. Frontiers in Immunology. 9. 2935–2935. 6 indexed citations
18.
Zhang, Xiaoping, Lin Zhu, Hongwu Wang, et al.. (2018). Interference with KCTD9 inhibits NK cell activation and ameliorates fulminant liver failure in mice. BMC Immunology. 19(1). 20–20. 9 indexed citations
20.
Liu, Xiaojuan, Rong Zhang, Guohong Deng, et al.. (2008). [Increased expression of KCTD9, a novel potassium channel related gene, correlates with disease severity in patients with viral hepatitis B].. PubMed. 16(11). 835–9. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026